016 - New diabetes medications - a podcast by Sean P. Kane, PharmD; Khyati Patel, PharmD
from 2014-11-04T11:00
::
::
In this episode, we discuss newly approved agents for diabetes mellitus: Afrezza (inhaled human insulin), SGLT2 inhibitors (Invokana, Farxiga, Jardiance), and long-acting GLP-1 agonists (Bydureon, Tanzeum).
Further episodes of HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast
Further podcasts by Sean P. Kane, PharmD; Khyati Patel, PharmD
Website of Sean P. Kane, PharmD; Khyati Patel, PharmD